SCI时时刷

search
Regional Formularies in Italy: current state and future perspectives
Jommi C, Pippo L, Bortolami A et al. Il governo dell’assistenza farmaceutica in Italia: il ruolo di ...
The future of drugs distribution in the National Health System
Osservatorio Farmaci Cergas, Università Bocconi. Report n. 42 – Report annuale per il 2021 https://c...
Orphan drugs in Italy: availability and time-to-access at regional level
European Medicines Agency. Human regulatory. Orphan designation. https://www.ema.europa.eu/en/human-...
Time to market access in Italy: duration of the P&R process for rare disease drugs
Kwon HY, Kim H, Godman B. Availability and Affordability of Drugs With a Conditional Approval by the...
Unmet need: definitions, literature evidence and implications for HTA
Caprari F, Alfano A, Buzzetti G, et al. [Unmet clinical need and new therapeutic options.]. Recenti ...
Good practices for the development of budget impact models at regional level
Linee guida per la compilazione del dossier a supporto della domanda di rimborsabilità e prezzo di u...
Drugs territorialization in the era of PNRR: perspectives, opportunities and considerations from a panel of experts
1.Marata AM, Marrocco W, Arcangeli E, Battistini M, Buzzetti G, Candido R, Casadei G, Cattel F, Cavaliere A, Consoli A, Co...
Drugs price and reimbursement regulation: comparators, endpoints and role of the cost-effectiveness
1.Jommi C, Apolone G, Scroccaro G, Acciai V, Addis A, Ardizzoni A, Bernardini R, Bortolami A, Brigido A, Buzzetti G, Canon...
Budget Impact analysis of a new system of care in Parkinson’s disease patients
European Parkinson’s Disease Association. What is Parkinson’s disease? Online https://www.epda.eu.co...